SCHEMBL10592010

SCHEMBL10592010

COC1=CC2=C(CC1=O)Sc1cc(SC)ccc1N2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOX1 Q9Y5S8 2/20 0.39
▸ MEN1 O00255 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ FGB P02675 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ SNCA P37840 2/20 0.34
▸ LMNA P02545 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813228 0.84 SNCA (0.52) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10591899 0.84 NOX1 (0.43) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10590497 0.80 MAPT (0.45) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10593297 0.69 EPHX2 (0.47) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10592030 0.66 SNCA (0.44) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10591060 0.64 SNCA (0.55) NOX1MEN1MAPTMAPK1HTT
SCHEMBL1201818 0.64 L3MBTL1 (0.45) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10593152 0.63 SNCA (0.52) NOX1MEN1MAPTMAPK1HTT
SCHEMBL9813116 0.60 NOX1 (0.41) NOX1MEN1MAPTMAPK1HTT
SCHEMBL10591877 0.59 EPHX2 (0.48) NOX1MEN1MAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0115394-B1 PHENOTHIAZONE DERIVATIVES AND ANALOGS MERCK FROSST CANADA INC. (CA) 1989-06-28 — — EP disclosed
EP-0155623-A2 Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition MERCK & CO. INC. (US) 1985-09-25 — — EP disclosed
EP-0115394-A2 Phenothiazone derivatives and analogs MERCK FROSST CANADA INC. (CA) 1984-08-08 — — EP disclosed
Send feedback